FDAFDA · Food and drugs·Recall number D-1611-2014
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Published October 8, 2014 · Recall initiated: September 15, 2014
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CREON
- Manufacturer
- AbbVie Inc
- Distributor
- US: Nationwide
- UPC
- 0300322637701
- Lot
- Lot #: 1020156; Expiry: 3/31/2016
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.